Back to Search
Start Over
Ustekinumab Demonstrates Lower Uveitis Risk in Moderate to Severe Psoriasis Patients Compared with Tumor Necrosis Factor-α Inhibitors.
- Source :
-
Acta dermato-venereologica [Acta Derm Venereol] 2024 Sep 09; Vol. 104, pp. adv34206. Date of Electronic Publication: 2024 Sep 09. - Publication Year :
- 2024
- Subjects :
- Humans
Female
Male
Middle Aged
Adult
Risk Factors
Tumor Necrosis Factor-alpha antagonists & inhibitors
Adalimumab therapeutic use
Adalimumab adverse effects
Treatment Outcome
Etanercept therapeutic use
Etanercept adverse effects
Risk Assessment
Dermatologic Agents therapeutic use
Dermatologic Agents adverse effects
Infliximab therapeutic use
Infliximab adverse effects
Psoriasis drug therapy
Ustekinumab therapeutic use
Ustekinumab adverse effects
Uveitis drug therapy
Severity of Illness Index
Subjects
Details
- Language :
- English
- ISSN :
- 1651-2057
- Volume :
- 104
- Database :
- MEDLINE
- Journal :
- Acta dermato-venereologica
- Publication Type :
- Academic Journal
- Accession number :
- 39248291
- Full Text :
- https://doi.org/10.2340/actadv.v104.34206